Breast cancer molecular subtype and relationship with clinicopathological profiles among Vietnamese women: A retrospective study

被引:3
|
作者
Nguyen, Thi Minh Thuc [1 ,3 ]
Le, Roanh Dinh [1 ]
Nguyen, Chu Van [1 ,2 ]
机构
[1] Ha Noi Med Univ, Hanoi, Vietnam
[2] Natl Canc Hosp, Hanoi, Vietnam
[3] Hanoi Med Univ, 1,Ton Tung St,Dong Dist,Kim Lien Ward, Hanoi, Vietnam
关键词
Breast cancer; Molecular subtypes; Clinicopathological profiles; Relationship; Distribution; INTERNATIONAL EXPERT CONSENSUS; PATHOLOGISTS GUIDELINE RECOMMENDATIONS; PRIMARY THERAPY; AMERICAN-SOCIETY; CLASSIFICATION; STRATEGIES; HIGHLIGHTS; MANAGEMENT; FEATURES; ESTROGEN;
D O I
10.1016/j.prp.2023.154819
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Molecular subtypes play an important role in predicting prognosis and guiding treatment for breast cancer. Having a better knowledge of ethnic molecular features is essential.Objectives: Determining the distribution of various breast cancer molecular subtypes and investigating the relationship between these subtypes and clinicopathological features. Methods: Retrospective data was collected from Hanoi National Cancer Hospital and Bach Mai Hospital that included 274 women diagnosed with invasive breast cancer between January 2017 and June 2019. Patients were categorized into five subtypes according to the 2015 St. Gallen molecular classification. The variables analyzed were molecular subtypes and tumor-related characteristics. To evaluate the relationship between these subtypes and clinicopathological features, a Chi-squared test and Fisher exact test were performed. Results: The most prominent subtype was Luminal A (33.2%), followed by Luminal B/Her2- (19.7%) and Luminal B/Her2 + (17.5%), then HER2 overexpression (16.4%), whereas triple negative was the least popular subtype (13.1%). Particularly, 33.9% of all patients, including the Luminal B/Her2 + and the HER2 overexpressing groups, were Her2 positive. There was a statistically significant difference between molecular subtypes and histological type (p = 0.01), tumor grade (p < 0.001), but it was independent of age, tumor size, lymph node metastasis, and lymphovascular invasion.Conclusions: In contrast to the triple negative variant, the Luminal A variant is the most common among Vietnamese women. The rate of positive tests for HER2 was rather high. These subtypes were closely related to tumor grade and histopathological type. Understanding the molecular subtypes and their relation to clinicopathological features helps clinicians with patient treatment, and prognosis. The application of the 2015 St. Gallen molecular classification should be recommended for use in clinical practice.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Breast cancer subtype subsequent to a benign breast biopsy among African American women
    Ruterbusch, Julie J.
    Cote, Michele L.
    Boerner, Julie
    Abdulfatah, Eman
    Alosh, Baraa
    Pardeshi, Vishakha
    Daaboul, M. H. D. Fayez
    Roquiz, Woodlyne
    Ali-Fehmi, Rouba
    Bandyopadhyay, Sudeshna
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [32] Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women
    Hien Minh Nguyen
    Minh Quang Dao
    BREAST CANCER-TARGETS AND THERAPY, 2019, 11 : 143 - 150
  • [33] Health-Related Quality of Life Among Vietnamese Breast Cancer Women
    Tran Thanh Huong
    Trinh Ngoc Linh
    Hoang Yen
    Nguyen Thuy Linh
    Vu Thu Thao
    CANCER CONTROL, 2019, 26 (01)
  • [34] Barriers to breast and cervical cancer screening among Vietnamese-American women
    McPhee, SJ
    Bird, JA
    Davis, T
    Ha, NT
    Jenkins, CNH
    Le, B
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1997, 13 (03) : 205 - 213
  • [35] Breast cancer in young women: A clinicopathological study of an argentinian population
    Cabrera Cantoni, A. A.
    Roses Videla, M. P.
    Videla de Roses, A.
    VIRCHOWS ARCHIV, 2016, 469 : S64 - S64
  • [36] Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women
    Sirisena, Nirmala Dushyanthi
    Adeyemo, Adebowale
    Kuruppu, Anchala Ishani
    Samaranayake, Nilakshi
    Dissanayake, Vajira Harshadeva Weerabaddana
    JOURNAL OF BREAST CANCER, 2018, 21 (02) : 165 - 172
  • [37] Breast cancer survival by immunohistochemistry-determined subtype: A retrospective study
    Erazo Valle-Solis, Aura
    Pabel Miranda-Aguirre, Arturo
    Mora-Perez, Josue
    Antonio Pineda-Juarez, Juan
    Ernesto Gallardo-Valencia, Luis
    Santana, Liberio
    Cervantes-Sanchez, Guadalupe
    Cardenas-Cardenas, Eduardo
    GACETA MEDICA DE MEXICO, 2019, 155 : S39 - S43
  • [38] Evaluation of types and treatment protocols for breast cancer among Palestinian women: a retrospective study
    Al-Ramahi, Rowa'
    Nazzal, Dalia
    Mustafa, Dalal
    Halabi, Eman
    Gnimat, Samah
    Gayada, Sara
    LANCET, 2019, 393 : 42 - 42
  • [39] Immunohistochemical subtype of breast cancer among Lao Women: A study in limited resource setting of Lao PDR
    Luangxay, Thitsamay
    Virachith, Siriphone
    MODERN PATHOLOGY, 2018, 31 : 87 - 87
  • [40] Immunohistochemical subtype of breast cancer among Lao Women: A study in limited resource setting of Lao PDR
    Luangxay, Thitsamay
    Virachith, Siriphone
    LABORATORY INVESTIGATION, 2018, 98 : 87 - 87